| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.63e-05 | 107 | 100 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.48e-04 | 4 | 100 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.48e-04 | 4 | 100 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.48e-04 | 4 | 100 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.48e-04 | 4 | 100 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 2.46e-04 | 5 | 100 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 2.46e-04 | 5 | 100 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 2.46e-04 | 5 | 100 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 2.46e-04 | 5 | 100 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 2.46e-04 | 5 | 100 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 2.46e-04 | 5 | 100 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 2.46e-04 | 5 | 100 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.65e-04 | 28 | 100 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 3.68e-04 | 6 | 100 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 5.13e-04 | 7 | 100 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 6.36e-04 | 78 | 100 | 4 | GO:0051536 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 6.82e-04 | 8 | 100 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 6.82e-04 | 8 | 100 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 6.82e-04 | 8 | 100 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.10e-04 | 35 | 100 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | metal cluster binding | 8.04e-04 | 83 | 100 | 4 | GO:0051540 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 8.74e-04 | 9 | 100 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 8.74e-04 | 9 | 100 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.09e-03 | 10 | 100 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.09e-03 | 10 | 100 | 2 | GO:0032052 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.29e-03 | 239 | 100 | 6 | GO:0031406 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 1.68e-03 | 47 | 100 | 3 | GO:0051539 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.76e-03 | 254 | 100 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.79e-03 | 48 | 100 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.90e-03 | 49 | 100 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 2.17e-03 | 14 | 100 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 2.17e-03 | 14 | 100 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.79e-03 | 56 | 100 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.28e-03 | 288 | 100 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.72e-03 | 62 | 100 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.20e-03 | 211 | 100 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 4.45e-03 | 20 | 100 | 2 | GO:0004303 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.70e-06 | 7 | 99 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.70e-06 | 7 | 99 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | LIAS GALE CES1 UGT1A5 INSR IREB2 ACOT6 PTGIS ANKH AKR1C1 AKR1C2 TXNRD1 UGT1A4 UGT1A3 ACAD11 ASS1 AHCY | 1.07e-05 | 1058 | 99 | 17 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | LIAS GALE CES1 UGT1A5 INSR IREB2 ACOT6 PTGIS ANKH AKR1C1 AKR1C2 TXNRD1 UGT1A4 UGT1A3 ACAD11 ASS1 AHCY | 1.15e-05 | 1064 | 99 | 17 | GO:0006082 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA4F DIP2B SLC11A2 WNT7A CDH23 SPG11 PLXNB2 GDNF SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 CNTN2 | 1.32e-05 | 748 | 99 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | LIAS GALE CES1 UGT1A5 INSR IREB2 ACOT6 PTGIS AKR1C1 AKR1C2 TXNRD1 UGT1A4 UGT1A3 ACAD11 ASS1 AHCY | 3.21e-05 | 1035 | 99 | 16 | GO:0019752 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA4F DIP2B SLC11A2 WNT7A SLC26A5 CDH23 SPG11 PLXNB2 GDNF SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 IHH CNTN2 EPB42 | 4.99e-05 | 1194 | 99 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 8.09e-05 | 375 | 99 | 9 | GO:0007162 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA4F DIP2B SLC11A2 WNT7A SPG11 PLXNB2 GDNF SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 CNTN2 | 1.19e-04 | 802 | 99 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.33e-04 | 313 | 99 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.34e-04 | 21 | 99 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.36e-04 | 4 | 99 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.36e-04 | 4 | 99 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.36e-04 | 4 | 99 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.36e-04 | 4 | 99 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA4F DIP2B SLC11A2 WNT7A SPG11 PLXNB2 GDNF SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 CNTN2 | 1.47e-04 | 819 | 99 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | parturition | 1.55e-04 | 22 | 99 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | LIAS MYADM DUSP1 WNT7A CDH23 PLXNB2 GDNF TXNRD1 TENM4 MEGF8 IHH EXOC4 | 1.57e-04 | 713 | 99 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA4F DIP2B SLC11A2 WNT7A SPG11 PLXNB2 GDNF SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 CNTN2 | 1.59e-04 | 826 | 99 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.77e-04 | 23 | 99 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | neuron development | SEMA4F DIP2B SLC11A2 WNT7A CDH23 MPDZ SPG11 PLXNB2 GDNF NCDN SPTBN4 TENM4 PTPRD CELSR3 CELSR2 MEGF8 IHH CNTN2 | 1.88e-04 | 1463 | 99 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | LIAS GALE CES1 UGT1A5 INSR ACOT6 PTGIS AKR1C1 AKR1C2 UGT1A4 UGT1A3 ACAD11 | 1.97e-04 | 731 | 99 | 12 | GO:0032787 |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.26e-04 | 5 | 99 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.26e-04 | 5 | 99 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.33e-04 | 115 | 99 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.57e-04 | 26 | 99 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.57e-04 | 26 | 99 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 3.22e-04 | 28 | 99 | 3 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 3.22e-04 | 28 | 99 | 3 | GO:0007413 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.29e-04 | 192 | 99 | 6 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of axon diameter | 3.38e-04 | 6 | 99 | 2 | GO:0031133 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 3.38e-04 | 6 | 99 | 2 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 3.38e-04 | 6 | 99 | 2 | GO:0016095 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 3.58e-04 | 29 | 99 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA4F DIP2B WNT7A SPG11 PLXNB2 GDNF SPTBN4 CELSR3 MEGF8 CNTN2 | 3.90e-04 | 566 | 99 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA4F DIP2B SLC11A2 WNT7A CDH23 MPDZ SPG11 PLXNB2 GDNF NCDN SPTBN4 PTPRD CELSR3 CELSR2 MEGF8 CNTN2 | 3.93e-04 | 1285 | 99 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | cellular response to ketone | 4.10e-04 | 130 | 99 | 5 | GO:1901655 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 4.10e-04 | 130 | 99 | 5 | GO:0097306 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 4.55e-04 | 133 | 99 | 5 | GO:0006766 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 4.71e-04 | 7 | 99 | 2 | GO:1900052 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level iron ion homeostasis | 4.81e-04 | 32 | 99 | 3 | GO:0060586 | |
| GeneOntologyBiologicalProcess | cholesterol efflux | 5.17e-04 | 77 | 99 | 4 | GO:0033344 | |
| GeneOntologyBiologicalProcess | gastrulation | 5.56e-04 | 212 | 99 | 6 | GO:0007369 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 6.26e-04 | 81 | 99 | 4 | GO:0071384 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 6.83e-04 | 36 | 99 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 8.03e-04 | 9 | 99 | 2 | GO:0044597 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 8.03e-04 | 9 | 99 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 8.32e-04 | 412 | 99 | 8 | GO:0006066 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level chemical homeostasis | 9.30e-04 | 90 | 99 | 4 | GO:0140962 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 9.32e-04 | 40 | 99 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell activation | 1.00e-03 | 10 | 99 | 2 | GO:0014719 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.00e-03 | 10 | 99 | 2 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.00e-03 | 10 | 99 | 2 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.00e-03 | 10 | 99 | 2 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.00e-03 | 10 | 99 | 2 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.00e-03 | 10 | 99 | 2 | GO:0030647 | |
| GeneOntologyBiologicalProcess | axon development | SEMA4F DIP2B WNT7A SPG11 PLXNB2 GDNF SPTBN4 CELSR3 MEGF8 CNTN2 | 1.03e-03 | 642 | 99 | 10 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | 1.03e-03 | 426 | 99 | 8 | GO:0032535 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.07e-03 | 42 | 99 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.22e-03 | 11 | 99 | 2 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.22e-03 | 11 | 99 | 2 | GO:0016115 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 1.23e-03 | 97 | 99 | 4 | GO:0045428 | |
| GeneOntologyBiologicalProcess | bone resorption | 1.33e-03 | 99 | 99 | 4 | GO:0045453 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 1.38e-03 | 100 | 99 | 4 | GO:0080164 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.40e-03 | 46 | 99 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | SLC11A2 CES1 ABCA12 ACP5 CDH23 IREB2 LRRK1 ANKH NCDN SLC35D3 IHH CNTN2 EPB42 | 1.43e-03 | 1043 | 99 | 13 | GO:0048871 |
| MousePheno | parturition failure | 1.73e-05 | 10 | 75 | 3 | MP:0012010 | |
| MousePheno | club-shaped femur | 2.84e-05 | 2 | 75 | 2 | MP:0030791 | |
| MousePheno | abnormal cerebellar granule cell migration | 5.17e-05 | 14 | 75 | 3 | MP:0009977 | |
| MousePheno | increased bone mineral content | 7.00e-05 | 258 | 75 | 8 | MP:0010123 | |
| MousePheno | abnormal gait | MARVELD1 WNT7A CDH23 IREB2 SPG11 LRRK1 ANKH AKR1C1 AKR1C2 SPTBN4 ASS1 | 9.62e-05 | 520 | 75 | 11 | MP:0001406 |
| MousePheno | abnormal oligodendrocyte morphology | 1.58e-04 | 51 | 75 | 4 | MP:0000953 | |
| MousePheno | distended duodenum | 1.69e-04 | 4 | 75 | 2 | MP:0011881 | |
| Domain | Plexin_repeat | 2.48e-05 | 32 | 100 | 4 | IPR002165 | |
| Domain | PSI | 2.48e-05 | 32 | 100 | 4 | PF01437 | |
| Domain | PSI | 1.06e-04 | 46 | 100 | 4 | SM00423 | |
| Domain | UDPGT | 1.85e-04 | 21 | 100 | 3 | PF00201 | |
| Domain | UDPGT | 1.85e-04 | 21 | 100 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.85e-04 | 21 | 100 | 3 | IPR002213 | |
| Domain | YIPPEE | 2.81e-04 | 5 | 100 | 2 | PS51792 | |
| Domain | - | 3.75e-04 | 248 | 100 | 7 | 1.25.40.20 | |
| Domain | ANK | 4.03e-04 | 251 | 100 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 4.23e-04 | 253 | 100 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.33e-04 | 254 | 100 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.33e-04 | 254 | 100 | 7 | PS50297 | |
| Domain | Ankyrin_rpt | 5.21e-04 | 262 | 100 | 7 | IPR002110 | |
| Domain | EGF_LAM_2 | 5.44e-04 | 30 | 100 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.44e-04 | 30 | 100 | 3 | PS01248 | |
| Domain | Yippee/Mis18/Cereblon | 7.78e-04 | 8 | 100 | 2 | IPR004910 | |
| Domain | Yippee-Mis18 | 7.78e-04 | 8 | 100 | 2 | PF03226 | |
| Domain | EGF_Lam | 8.61e-04 | 35 | 100 | 3 | SM00180 | |
| Domain | Laminin_EGF | 8.61e-04 | 35 | 100 | 3 | PF00053 | |
| Domain | Ank_2 | 1.05e-03 | 215 | 100 | 6 | PF12796 | |
| Domain | Laminin_EGF | 1.10e-03 | 38 | 100 | 3 | IPR002049 | |
| Domain | ConA-like_dom | 1.16e-03 | 219 | 100 | 6 | IPR013320 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.24e-03 | 10 | 100 | 2 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.24e-03 | 10 | 100 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.24e-03 | 10 | 100 | 2 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.24e-03 | 10 | 100 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.24e-03 | 10 | 100 | 2 | IPR020471 | |
| Domain | Ank | 1.42e-03 | 228 | 100 | 6 | PF00023 | |
| Domain | GAIN_dom_N | 1.51e-03 | 11 | 100 | 2 | IPR032471 | |
| Domain | GAIN | 1.51e-03 | 11 | 100 | 2 | PF16489 | |
| Domain | PSI | 1.68e-03 | 44 | 100 | 3 | IPR016201 | |
| Domain | - | 3.24e-03 | 16 | 100 | 2 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.66e-03 | 17 | 100 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 3.66e-03 | 17 | 100 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.66e-03 | 17 | 100 | 2 | IPR001395 | |
| Domain | Laminin_G | 3.71e-03 | 58 | 100 | 3 | IPR001791 | |
| Domain | Wnt | 4.57e-03 | 19 | 100 | 2 | IPR005817 | |
| Domain | WNT1 | 4.57e-03 | 19 | 100 | 2 | PS00246 | |
| Domain | Wnt_CS | 4.57e-03 | 19 | 100 | 2 | IPR018161 | |
| Domain | wnt | 4.57e-03 | 19 | 100 | 2 | PF00110 | |
| Domain | WNT1 | 4.57e-03 | 19 | 100 | 2 | SM00097 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.24e-07 | 23 | 76 | 5 | MM16639 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.12e-05 | 55 | 76 | 5 | M14933 | |
| Pathway | WP_FERROPTOSIS | 2.37e-05 | 64 | 76 | 5 | M39768 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.67e-05 | 70 | 76 | 5 | M16794 | |
| Pathway | REACTOME_DRUG_ADME | 4.31e-05 | 119 | 76 | 6 | MM15692 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 6.54e-05 | 15 | 76 | 3 | MM14870 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 6.54e-05 | 15 | 76 | 3 | MM15697 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.99e-05 | 44 | 76 | 4 | M45014 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 9.83e-05 | 45 | 76 | 4 | M39355 | |
| Pathway | REACTOME_ASPIRIN_ADME | 9.83e-05 | 45 | 76 | 4 | MM15694 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.61e-04 | 20 | 76 | 3 | MM14721 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.61e-04 | 51 | 76 | 4 | M17726 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.81e-04 | 24 | 76 | 3 | MM14599 | |
| Pathway | REACTOME_DRUG_ADME | 3.01e-04 | 109 | 76 | 5 | M45012 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.18e-04 | 25 | 76 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.18e-04 | 25 | 76 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.18e-04 | 25 | 76 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 3.58e-04 | 26 | 76 | 3 | M39404 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 4.24e-04 | 6 | 76 | 2 | M39600 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.48e-04 | 28 | 76 | 3 | M19580 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 5.39e-04 | 189 | 76 | 6 | MM14772 | |
| Pathway | REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM | 5.92e-04 | 7 | 76 | 2 | M27092 | |
| Pathway | REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM | 5.92e-04 | 7 | 76 | 2 | MM14770 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 6.08e-04 | 72 | 76 | 4 | M9257 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 6.67e-04 | 32 | 76 | 3 | MM14719 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.01e-03 | 9 | 76 | 2 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.01e-03 | 9 | 76 | 2 | M47817 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.16e-03 | 219 | 76 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.19e-03 | 220 | 76 | 6 | M10320 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.26e-03 | 10 | 76 | 2 | M46430 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.39e-03 | 41 | 76 | 3 | M7399 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.53e-03 | 11 | 76 | 2 | M47812 | |
| Pathway | WP_IRON_METABOLISM_IN_PLACENTA | 1.83e-03 | 12 | 76 | 2 | M39660 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.33e-07 | 211 | 103 | 8 | 24097068 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.72e-07 | 19 | 103 | 4 | 23281178 | |
| Pubmed | Quantitative traits for the tail suspension test: automation, optimization, and BXD RI mapping. | 8.75e-07 | 7 | 103 | 3 | 17619104 | |
| Pubmed | 1.41e-06 | 28 | 103 | 4 | 20689807 | ||
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 9693030 | ||
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 22511988 | ||
| Pubmed | 2.09e-06 | 9 | 103 | 3 | 1339448 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 23642732 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 11465080 | ||
| Pubmed | 2.98e-06 | 10 | 103 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.98e-06 | 10 | 103 | 3 | 22558097 | |
| Pubmed | 5.44e-06 | 12 | 103 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 5.44e-06 | 12 | 103 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 7.06e-06 | 13 | 103 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 7.06e-06 | 13 | 103 | 3 | 25246029 | |
| Pubmed | Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus. | 8.69e-06 | 2 | 103 | 2 | 26871237 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11994298 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8573067 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11514561 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8068691 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15492289 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24641623 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 10790539 | ||
| Pubmed | cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. | 8.69e-06 | 2 | 103 | 2 | 8011662 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18654764 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 21217827 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26934124 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17264798 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8486699 | ||
| Pubmed | Zinc induces iron uptake and DMT1 expression in Caco-2 cells via a PI3K/IRP2 dependent mechanism. | 8.69e-06 | 2 | 103 | 2 | 31092704 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14570768 | ||
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 8.97e-06 | 14 | 103 | 3 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 8.97e-06 | 14 | 103 | 3 | 14672974 | |
| Pubmed | 8.97e-06 | 14 | 103 | 3 | 9295054 | ||
| Pubmed | 1.03e-05 | 251 | 103 | 7 | 29031500 | ||
| Pubmed | 1.17e-05 | 47 | 103 | 4 | 33141892 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.37e-05 | 16 | 103 | 3 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.66e-05 | 17 | 103 | 3 | 20639394 | |
| Pubmed | 1.73e-05 | 107 | 103 | 5 | 11347906 | ||
| Pubmed | Foxl2 functions in sex determination and histogenesis throughout mouse ovary development. | 2.20e-05 | 55 | 103 | 4 | 19538736 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 19320734 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18177727 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 2.60e-05 | 3 | 103 | 2 | 31780644 | |
| Pubmed | Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. | 2.60e-05 | 3 | 103 | 2 | 20195289 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21232532 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 13678667 | ||
| Pubmed | Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts. | 2.60e-05 | 3 | 103 | 2 | 22064385 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 12051676 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 10452915 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 11677057 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23611809 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18508192 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21383159 | ||
| Pubmed | Plexin-B2 controls the development of cerebellar granule cells. | 3.23e-05 | 21 | 103 | 3 | 17409257 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DIP2B POLR1A PPP1R12A INSR ANKH NCDN SGK2 SPTBN4 ANKRD44 PCNX4 ASS1 SEL1L3 DOCK6 ALG12 EXOC4 | 3.28e-05 | 1489 | 103 | 15 | 28611215 |
| Pubmed | 4.54e-05 | 66 | 103 | 4 | 19898482 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 4.88e-05 | 24 | 103 | 3 | 24625756 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 5.19e-05 | 4 | 103 | 2 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 5.19e-05 | 4 | 103 | 2 | 16508162 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 5.19e-05 | 4 | 103 | 2 | 14967952 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 5.19e-05 | 4 | 103 | 2 | 15193432 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 5.19e-05 | 4 | 103 | 2 | 18223459 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 5.19e-05 | 4 | 103 | 2 | 31479646 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11735226 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 20633051 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 15222881 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 16191478 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 15577209 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 12644700 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 10702227 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 28714470 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 9535849 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17034817 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17629694 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 5.19e-05 | 4 | 103 | 2 | 37224017 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 9271343 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11175792 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 5.19e-05 | 4 | 103 | 2 | 29764944 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 10526179 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17888864 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17442338 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 28329705 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 16018803 | ||
| Pubmed | Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. | 5.19e-05 | 4 | 103 | 2 | 18794728 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 35100259 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 17272929 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 5.19e-05 | 4 | 103 | 2 | 18667791 | |
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 5.19e-05 | 4 | 103 | 2 | 11850187 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 28259989 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 21521174 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 8274401 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 16511129 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 10803568 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 5.19e-05 | 4 | 103 | 2 | 18417546 | |
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 5.19e-05 | 4 | 103 | 2 | 34590152 | |
| Cytoband | 2q37 | 4.85e-05 | 31 | 104 | 3 | 2q37 | |
| Cytoband | 10p15-p14 | 7.58e-05 | 6 | 104 | 2 | 10p15-p14 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.69e-05 | 3 | 64 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.69e-05 | 3 | 64 | 2 | 1189 | |
| GeneFamily | Yippee like family | 1.23e-04 | 5 | 64 | 2 | 1130 | |
| GeneFamily | UDP glucuronosyltransferases | 1.95e-04 | 32 | 64 | 3 | 363 | |
| GeneFamily | Ankyrin repeat domain containing | 2.12e-04 | 242 | 64 | 6 | 403 | |
| GeneFamily | Aldo-keto reductases | 1.26e-03 | 15 | 64 | 2 | 399 | |
| GeneFamily | Wnt family|Endogenous ligands | 2.03e-03 | 19 | 64 | 2 | 360 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP | 1.45e-05 | 200 | 103 | 7 | M6019 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM SLC11A2 MARVELD1 DRAM1 DUSP1 ARMC9 PLXNB2 GDNF ANKH SLC52A2 ALG12 SOAT1 | 1.52e-05 | 681 | 103 | 12 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM SLC11A2 MARVELD1 DRAM1 DUSP1 ARMC9 PLXNB2 GDNF ANKH SLC52A2 ALG12 SOAT1 | 2.08e-05 | 703 | 103 | 12 | MM1055 |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.95e-08 | 197 | 103 | 8 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-07 | 190 | 103 | 7 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.72e-07 | 196 | 103 | 7 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.85e-07 | 197 | 103 | 7 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.04e-06 | 181 | 103 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-06 | 182 | 103 | 6 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 186 | 103 | 6 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 190 | 103 | 6 | 95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb | |
| ToppCell | IPF-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 5.50e-06 | 191 | 103 | 6 | 267e1192aaec468c1a59eb24848b37e0e18cbc44 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.19e-06 | 195 | 103 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.37e-06 | 196 | 103 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.37e-06 | 196 | 103 | 6 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.37e-06 | 196 | 103 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.75e-06 | 198 | 103 | 6 | e4cbe4032dba0da3fd46817ea9ad86ba9217f747 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.85e-05 | 153 | 103 | 5 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.46e-05 | 168 | 103 | 5 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 169 | 103 | 5 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-05 | 171 | 103 | 5 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 171 | 103 | 5 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.12e-05 | 173 | 103 | 5 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | Immune_cells-Monocytes|Immune_cells / Lineage and Cell class | 5.12e-05 | 173 | 103 | 5 | 3eced40a65453a023a1673658592e7e2a099119b | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.26e-05 | 174 | 103 | 5 | 68914ec843f58ecff3e6412544a341daf8a01cac | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.56e-05 | 176 | 103 | 5 | fc5787946f5a10056d326d070620575ae4081836 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.56e-05 | 176 | 103 | 5 | 5daaba0853afe7d20d4635169ccd4f96e735b938 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 181 | 103 | 5 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 181 | 103 | 5 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.34e-05 | 181 | 103 | 5 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Esophagus_Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.47e-05 | 93 | 103 | 4 | 4ab8c28f7c47129ac633bcfdc7ccc8f7793464d5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 182 | 103 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.68e-05 | 183 | 103 | 5 | 02deb595819fb864a934fd0fcaad684f1ca42964 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 7.04e-05 | 185 | 103 | 5 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Frontal_cortex-Endothelial|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.59e-05 | 188 | 103 | 5 | a43392dbd10fc7dbfb31be39b8af8a7ea121c894 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 8.18e-05 | 191 | 103 | 5 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.59e-05 | 193 | 103 | 5 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | 10x5'-Liver|World / Manually curated celltypes from each tissue | 8.59e-05 | 193 | 103 | 5 | d010d47d763c99e68aede59345392f2a8c77d7ac | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 193 | 103 | 5 | 21c397912f2dd1f4115cddbdc01a6a9beb1332cc | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 8.59e-05 | 193 | 103 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.59e-05 | 193 | 103 | 5 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.80e-05 | 194 | 103 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | Macrophages-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.80e-05 | 194 | 103 | 5 | 543b856b0fd883550c8f14baeae08fb9bf1a7768 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_EM_CTLs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.01e-05 | 195 | 103 | 5 | 7df67ad5c62235474ee56ea07a957253d45f066b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | 19347b7e8d3ea67e0fddd948078abcab9d364a2d | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 460e12044905370797fd9774e99c3aedaebfe343 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | 55b4030f078173b0136990fae87b6eaf44c58f33 | |
| ToppCell | Macrophages-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.01e-05 | 195 | 103 | 5 | e48bf57e6da23fbb4637a02387155f825455c49f | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | ff9f6b38f41dc5660b746fe40ceaddfb2958acd3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.23e-05 | 196 | 103 | 5 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 1ff4b41817556a6e573f0737819a5cc24a7ef821 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.23e-05 | 196 | 103 | 5 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.23e-05 | 196 | 103 | 5 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 8e909c31733762646359fe78b645cbd60237459e | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.23e-05 | 196 | 103 | 5 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-05 | 197 | 103 | 5 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 197 | 103 | 5 | e5ab45cfe4ebd02ca25029d87bece70dfbb4adc4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-05 | 197 | 103 | 5 | fc718a254bda4df2d62975d04393492fb75ab305 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.69e-05 | 198 | 103 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.69e-05 | 198 | 103 | 5 | 61292a2b5aacb6080a679a31b70a211bdec59a3b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.69e-05 | 198 | 103 | 5 | 382ad6ebc6e0274ace361de72c0a3df05c846456 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-D|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.69e-05 | 198 | 103 | 5 | fd14efd8e6c74a04bde985c08dc34217c0ef1bab | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.69e-05 | 198 | 103 | 5 | 778fee7020c82d11ff3984a8e482a23e5d58165f | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.69e-05 | 198 | 103 | 5 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 198 | 103 | 5 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.92e-05 | 199 | 103 | 5 | 08c7e631b2e203dd7dcb75a7f9377d292bc5a0fd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.92e-05 | 199 | 103 | 5 | 4338bf6cafc26c5d6497955d91914f84bacfacfa | |
| ToppCell | Bronchial_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.92e-05 | 199 | 103 | 5 | 53b87edccc89a3e8a6c5166472f9ef24fcba416c | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 9.92e-05 | 199 | 103 | 5 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-05 | 199 | 103 | 5 | 81b3cb41abbee9785041170d0469edc50b622d7e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.92e-05 | 199 | 103 | 5 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-05 | 199 | 103 | 5 | 3216fdaba8be8e8e715aceb2c29f1ad5cc02f8ae | |
| ToppCell | background-Hepatocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-04 | 200 | 103 | 5 | 423cca10df6ae0489a8fe7e7df87e70364dac022 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 200 | 103 | 5 | 2cca77b2c9d829daa674a844e068f2b083e90d6e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_suprabasal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.02e-04 | 200 | 103 | 5 | 92382ca82da3e435ccbee1c73261d55164d54779 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 128 | 103 | 4 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 141 | 103 | 4 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 141 | 103 | 4 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 142 | 103 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.16e-04 | 151 | 103 | 4 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.38e-04 | 153 | 103 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 154 | 103 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-04 | 154 | 103 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.60e-04 | 155 | 103 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.82e-04 | 157 | 103 | 4 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | Adult-Immune-mast_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.06e-04 | 159 | 103 | 4 | 9f53fe2e0f25448d62a591c8e528e9a49b5400d5 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Basal|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.18e-04 | 160 | 103 | 4 | f538ce75500773b5dda53fec4cde2f557d816f4e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 160 | 103 | 4 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| Drug | androsterone glucuronide | 3.30e-08 | 43 | 100 | 6 | CID000114833 | |
| Drug | 9-OH-risperidone | 1.29e-06 | 19 | 100 | 4 | CID000475100 | |
| Drug | Benzamidoxime hydrochloride | 1.98e-06 | 21 | 100 | 4 | CID000069186 | |
| Drug | amonafide | 2.41e-06 | 22 | 100 | 4 | CID000050515 | |
| Drug | phenanthridine | 2.91e-06 | 23 | 100 | 4 | CID000009189 | |
| Drug | phenolphthalein | 5.63e-06 | 58 | 100 | 5 | CID000004764 | |
| Drug | mono-(2-ethylhexyl)phthalate | ABCA12 DUSP1 INSR AOX1 CDH23 SLC5A9 GDNF TXNRD1 SPTBN4 PTPRD CELSR2 AHCY POPDC3 | 6.17e-06 | 658 | 100 | 13 | ctd:C016599 |
| Drug | AC1MRQNQ | 6.77e-06 | 9 | 100 | 3 | CID003522271 | |
| Drug | DHPASiU | 6.77e-06 | 9 | 100 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 6.77e-06 | 9 | 100 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 6.77e-06 | 9 | 100 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 6.77e-06 | 9 | 100 | 3 | CID005460873 | |
| Drug | AC1L1JAL | 7.65e-06 | 29 | 100 | 4 | CID000004954 | |
| Drug | trans-3'-hydroxycotinine | 7.65e-06 | 29 | 100 | 4 | CID000000414 | |
| Drug | dihydroartemisinin | 8.79e-06 | 30 | 100 | 4 | CID000107770 | |
| Drug | ketoprofen | 9.17e-06 | 64 | 100 | 5 | CID000003825 | |
| Drug | Meldola | 1.24e-05 | 68 | 100 | 5 | CID000081507 | |
| Drug | 4-nitrophenyl)imidazole | 1.32e-05 | 11 | 100 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 1.32e-05 | 11 | 100 | 3 | CID006442661 | |
| Drug | N-OH-DABZ | 1.76e-05 | 12 | 100 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.76e-05 | 12 | 100 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 1.76e-05 | 12 | 100 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.76e-05 | 12 | 100 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.76e-05 | 12 | 100 | 3 | CID000276709 | |
| Drug | catechol | 1.80e-05 | 257 | 100 | 8 | CID000000289 | |
| Drug | anisole | 1.85e-05 | 36 | 100 | 4 | CID000007519 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.91e-05 | 2 | 100 | 2 | DB07768 | |
| Drug | afloqualone | 1.91e-05 | 2 | 100 | 2 | ctd:C033541 | |
| Drug | 6beta-hydroxytestosterone | 2.07e-05 | 37 | 100 | 4 | CID000065543 | |
| Drug | tritanol | 2.28e-05 | 13 | 100 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.28e-05 | 13 | 100 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.28e-05 | 13 | 100 | 3 | CID000000411 | |
| Drug | acacetin | 2.31e-05 | 38 | 100 | 4 | CID005280442 | |
| Drug | Salicylic Acid | 2.56e-05 | 39 | 100 | 4 | ctd:D020156 | |
| Drug | propranolol glucuronide | 2.89e-05 | 14 | 100 | 3 | CID000119515 | |
| Drug | PCB-61 | 2.89e-05 | 14 | 100 | 3 | CID000036401 | |
| Drug | AC1Q6O8B | 3.13e-05 | 41 | 100 | 4 | CID000000334 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.60e-05 | 15 | 100 | 3 | CID000040469 | |
| Drug | afloqualone | 3.60e-05 | 15 | 100 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 3.60e-05 | 15 | 100 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.60e-05 | 15 | 100 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 3.60e-05 | 15 | 100 | 3 | CID000543743 | |
| Drug | 7,8-benzoquinoline | 3.79e-05 | 43 | 100 | 4 | CID000009191 | |
| Drug | quercetin-3,4'-diglucoside | 4.42e-05 | 16 | 100 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.42e-05 | 16 | 100 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.42e-05 | 16 | 100 | 3 | CID005497144 | |
| Drug | NSC9700 | MYH2 POLR1A UGT1A5 ACP5 INSR PTGIS AKR1C1 AKR1C2 UGT1A4 UGT1A3 IHH | 4.72e-05 | 578 | 100 | 11 | CID000005408 |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 5.35e-05 | 17 | 100 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 5.35e-05 | 17 | 100 | 3 | CID000037766 | |
| Drug | cyclopentanol | 5.71e-05 | 3 | 100 | 2 | ctd:C016327 | |
| Drug | cyclopentanone | 5.71e-05 | 3 | 100 | 2 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 5.71e-05 | 3 | 100 | 2 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 5.71e-05 | 3 | 100 | 2 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.71e-05 | 3 | 100 | 2 | ctd:C530610 | |
| Drug | AC1L1G0K | 6.38e-05 | 49 | 100 | 4 | CID000003473 | |
| Drug | SureCN12722713 | 6.39e-05 | 18 | 100 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 6.39e-05 | 18 | 100 | 3 | CID000152226 | |
| Drug | Br 2 | 6.39e-05 | 18 | 100 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 6.39e-05 | 18 | 100 | 3 | CID000036614 | |
| Drug | ApApG | 6.39e-05 | 18 | 100 | 3 | CID003081975 | |
| Drug | C1 11-32 | 6.39e-05 | 18 | 100 | 3 | CID000443077 | |
| Drug | C11131 | 6.39e-05 | 18 | 100 | 3 | CID000443076 | |
| Drug | beta-Naphthoflavone | CTSC UGT1A5 YPEL1 PTGFR AKR1C1 SGK2 TXNRD1 UGT1A4 UGT1A3 MEGF8 IHH EMP3 TRPV5 | 6.80e-05 | 828 | 100 | 13 | ctd:D019324 |
| Drug | deoxypyridinoline | 7.26e-05 | 98 | 100 | 5 | CID000105071 | |
| Drug | androstane-3,17-dione | 7.47e-05 | 51 | 100 | 4 | CID000000443 | |
| Drug | 5alpha-spirostan-3beta-ol | 7.57e-05 | 19 | 100 | 3 | CID000091433 | |
| Drug | almokalant | 7.57e-05 | 19 | 100 | 3 | CID003033962 | |
| Drug | 3-hydroxyandrostan-17-one | 8.79e-05 | 102 | 100 | 5 | CID000000225 | |
| Drug | tectochrysin | 8.88e-05 | 20 | 100 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 8.88e-05 | 20 | 100 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 8.88e-05 | 20 | 100 | 3 | CID000116545 | |
| Drug | HCG 004 | 9.36e-05 | 54 | 100 | 4 | CID000064928 | |
| Drug | allicin | 9.36e-05 | 54 | 100 | 4 | CID000065036 | |
| Drug | estrone-d4 | 9.92e-05 | 168 | 100 | 6 | CID000000698 | |
| Drug | estriol-16-glucuronide | 1.03e-04 | 21 | 100 | 3 | CID000122281 | |
| Drug | abequose | 1.03e-04 | 21 | 100 | 3 | CID000160540 | |
| Drug | Flunitrazepam | 1.03e-04 | 21 | 100 | 3 | ctd:D005445 | |
| Drug | coniferaldehyde | 1.03e-04 | 21 | 100 | 3 | ctd:C075384 | |
| Drug | dulcin | 1.03e-04 | 21 | 100 | 3 | CID000009013 | |
| Drug | Sodium Dodecyl Sulfate | 1.05e-04 | 106 | 100 | 5 | ctd:D012967 | |
| Drug | Invader | 1.08e-04 | 56 | 100 | 4 | CID006442259 | |
| Drug | 2,4,5-Trichlorophenoxyacetic Acid | 1.10e-04 | 107 | 100 | 5 | ctd:D015085 | |
| Drug | cloxazolam | 1.14e-04 | 4 | 100 | 2 | ctd:C005522 | |
| Drug | tetrahydrodeoxycorticosterone | 1.14e-04 | 4 | 100 | 2 | ctd:C009413 | |
| Drug | Pregnanes | 1.14e-04 | 4 | 100 | 2 | ctd:D011278 | |
| Drug | tetralol | 1.14e-04 | 4 | 100 | 2 | ctd:C019106 | |
| Drug | gliquidone | 1.14e-04 | 4 | 100 | 2 | ctd:C010969 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.14e-04 | 4 | 100 | 2 | ctd:C018156 | |
| Drug | N-methylpiperazine | 1.19e-04 | 22 | 100 | 3 | CID000053167 | |
| Drug | NSC740136 | 1.20e-04 | 109 | 100 | 5 | CID000003706 | |
| Drug | 4-nitrophenol | 1.32e-04 | 177 | 100 | 6 | CID000000980 | |
| Drug | SN-38G | 1.32e-04 | 59 | 100 | 4 | CID000443154 | |
| Drug | amidoxime | 1.37e-04 | 23 | 100 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.37e-04 | 23 | 100 | 3 | CID000066651 | |
| Drug | 3-OH | 1.51e-04 | 61 | 100 | 4 | CID000068152 | |
| Drug | Tranilast sodium | 1.55e-04 | 115 | 100 | 5 | CID000005527 | |
| Drug | AS-3201 | 1.56e-04 | 24 | 100 | 3 | CID000153948 | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; HL60; HT_HG-U133A | 1.68e-04 | 185 | 100 | 6 | 2916_UP | |
| Drug | 5-MOP | 1.76e-04 | 25 | 100 | 3 | CID000002355 | |
| Drug | AzMC | 1.76e-04 | 25 | 100 | 3 | CID000064986 | |
| Disease | Disorders of Sex Development | 1.35e-06 | 7 | 101 | 3 | C0036875 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.15e-06 | 8 | 101 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.22e-06 | 9 | 101 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.22e-06 | 9 | 101 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.59e-06 | 10 | 101 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 4.59e-06 | 10 | 101 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.59e-06 | 10 | 101 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 4.59e-06 | 10 | 101 | 3 | EFO_0800867 | |
| Disease | free androgen index | 5.74e-06 | 374 | 101 | 9 | EFO_0007005 | |
| Disease | histidine betaine (hercynine) measurement | 6.30e-06 | 11 | 101 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 6.30e-06 | 11 | 101 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 6.30e-06 | 11 | 101 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 6.30e-06 | 11 | 101 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.37e-06 | 12 | 101 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.37e-06 | 12 | 101 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 1.09e-05 | 13 | 101 | 3 | EFO_0802007 | |
| Disease | Endometrioma | 1.99e-05 | 161 | 101 | 6 | C0269102 | |
| Disease | Endometriosis | 1.99e-05 | 161 | 101 | 6 | C0014175 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.56e-05 | 17 | 101 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 3.06e-05 | 18 | 101 | 3 | EFO_0801382 | |
| Disease | Neoplasms, Hormone-Dependent | 3.47e-05 | 3 | 101 | 2 | C0027661 | |
| Disease | urate measurement, spine bone mineral density | 4.76e-05 | 58 | 101 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | tissue factor measurement | 4.95e-05 | 21 | 101 | 3 | EFO_0010623 | |
| Disease | Hermaphroditism | 1.15e-04 | 5 | 101 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 1.15e-04 | 5 | 101 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 1.15e-04 | 5 | 101 | 2 | C0033804 | |
| Disease | Intersex Conditions | 1.15e-04 | 5 | 101 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 1.15e-04 | 5 | 101 | 2 | C2930619 | |
| Disease | metabolite measurement | 1.33e-04 | 560 | 101 | 9 | EFO_0004725 | |
| Disease | xanthurenate measurement | 1.33e-04 | 29 | 101 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.48e-04 | 30 | 101 | 3 | EFO_0600017 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.80e-04 | 32 | 101 | 3 | DOID:332 (is_implicated_in) | |
| Disease | cholelithiasis | 2.42e-04 | 88 | 101 | 4 | EFO_0004799 | |
| Disease | X-24747 measurement | 3.20e-04 | 8 | 101 | 2 | EFO_0022135 | |
| Disease | white matter microstructure measurement | 3.96e-04 | 390 | 101 | 7 | EFO_0005674 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.06e-04 | 291 | 101 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | gallstones | 5.28e-04 | 108 | 101 | 4 | EFO_0004210 | |
| Disease | pregnenetriol sulfate measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0600039 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 7.49e-04 | 12 | 101 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 7.49e-04 | 12 | 101 | 2 | EFO_0008141 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 7.49e-04 | 12 | 101 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | 8.00e-04 | 869 | 101 | 10 | EFO_0004735 | |
| Disease | pregnenetriol disulfate measurement | 8.83e-04 | 13 | 101 | 2 | EFO_0800587 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 8.83e-04 | 13 | 101 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 9.46e-04 | 56 | 101 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 9.76e-04 | 220 | 101 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.02e-03 | 222 | 101 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.06e-03 | 224 | 101 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | glycine measurement | 1.28e-03 | 137 | 101 | 4 | EFO_0009767 | |
| Disease | response to methotrexate | 1.35e-03 | 16 | 101 | 2 | GO_0031427 | |
| Disease | Liver Cirrhosis, Experimental | 1.37e-03 | 774 | 101 | 9 | C0023893 | |
| Disease | partial epilepsy | 1.53e-03 | 17 | 101 | 2 | EFO_0004263 | |
| Disease | X-21441 measurement | 1.53e-03 | 17 | 101 | 2 | EFO_0800814 | |
| Disease | alpha-L-iduronidase measurement | 1.53e-03 | 17 | 101 | 2 | EFO_0020139 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.54e-03 | 144 | 101 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | Contact Dermatitis | 1.88e-03 | 71 | 101 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 1.88e-03 | 71 | 101 | 3 | C0162351 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.92e-03 | 153 | 101 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.92e-03 | 153 | 101 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.04e-03 | 260 | 101 | 5 | EFO_0008317 | |
| Disease | X-24309 measurement | 2.12e-03 | 20 | 101 | 2 | EFO_0800872 | |
| Disease | Disproportionate short stature | 2.37e-03 | 77 | 101 | 3 | C0878659 | |
| Disease | apolipoprotein A 1 measurement | 2.54e-03 | 848 | 101 | 9 | EFO_0004614 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.55e-03 | 274 | 101 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | progranulin measurement | 2.56e-03 | 22 | 101 | 2 | EFO_0004625 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.58e-03 | 166 | 101 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | thyroxine measurement | 2.93e-03 | 83 | 101 | 3 | EFO_0005130 | |
| Disease | hormone measurement | 3.03e-03 | 84 | 101 | 3 | EFO_0004730 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYHSLDVIGFLLAVV | 486 | P35503 | |
| YHAASGDVAELRVEL | 146 | Q6UXC1 | |
| VVFEAVAAGVAHSYV | 941 | Q6UXC1 | |
| VAAGVAHSYVALDDL | 946 | Q6UXC1 | |
| TYDGLALAAHENVVV | 151 | P23141 | |
| DAVIGHYSLLLQVSG | 111 | P16452 | |
| LYHAVIARVGAAVSE | 536 | P51689 | |
| LVVVGIGSVYFHATL | 71 | Q5QJU3 | |
| AAELGTEIAASLLYH | 476 | Q86UK0 | |
| VAAARGLEQHVALYL | 216 | Q96NS5 | |
| VALYLEHGADVGLRT | 226 | Q96NS5 | |
| RASVHAVLGEAIFYG | 371 | Q3I5F7 | |
| EDYEVALSVGHLASL | 466 | Q92624 | |
| GYLVLHVQAIDADAG | 521 | Q9HCU4 | |
| LAVHLLDSYLSAGRV | 131 | Q9H8S5 | |
| DLAGHNDTAIIGIYI | 2936 | Q9H251 | |
| AGTILYHAHLDIEAF | 286 | P00966 | |
| VSGLSHVDYALIAEE | 441 | Q709F0 | |
| LLVIGHLVVNAAYSA | 346 | Q9BV10 | |
| AAALVHIYLDGSVLV | 1026 | Q06278 | |
| FALGSIEGRVAIHYI | 231 | P78406 | |
| GRHSDLAALYTIVAV | 921 | Q9Y2K5 | |
| AIENAHVLLYLGDSV | 736 | P48200 | |
| LSVVRYLATAHIDGA | 181 | P53384 | |
| YLATAHIDGAVIITT | 186 | P53384 | |
| STYDGLALAAHENVV | 151 | Q9UKY3 | |
| AAFIISYVVAVLSGH | 21 | Q8N682 | |
| AHAAAILEGQLYVSG | 361 | A6NCF5 | |
| AIGAVIHYLLQVGSE | 371 | Q9UBB6 | |
| VAAYFGHTAVVQELL | 126 | Q38SD2 | |
| ADYHNLIGVTAELVD | 236 | Q7Z3E5 | |
| LAAAGVDHVILAVSY | 41 | Q9Y5P6 | |
| VFSVYVLHRGATLAA | 91 | Q96KN9 | |
| IYVAGLVAHSDLDER | 46 | O60506 | |
| HLINGAIAVFVYASD | 81 | P43088 | |
| YVANTVFHSILAGLA | 136 | Q63HM2 | |
| HLAVDEASGVVYLGA | 36 | O15031 | |
| AEAHFALIHYAGVVD | 576 | Q9UKX2 | |
| LTAATGERHDALYVV | 1446 | Q9P265 | |
| SVAHAVAAVGSRLYI | 1841 | Q7Z7M0 | |
| VALSGLDVYAHNVET | 226 | O43766 | |
| AINLLAYVADLVHSA | 301 | Q96S97 | |
| DLGHVALYVVAAVVS | 501 | P49281 | |
| TAIHLNVTDLGLGYE | 121 | P39905 | |
| LAVAYGHIDAVSLLL | 676 | Q8N8A2 | |
| VAVAALLLGAAGHLY | 16 | P06213 | |
| GVIYLVTITAAGVDH | 191 | P28065 | |
| YQELHVDSVGAAALL | 316 | Q04756 | |
| AGYIGSHTVLELLEA | 11 | Q14376 | |
| AVAAAHSVVLGYLQD | 351 | Q96A65 | |
| YKAAVIGTRLHAAVA | 46 | Q9NRX6 | |
| VHAAALVAEYLALLE | 1621 | Q96HP0 | |
| LAGAYHAVVLLDERS | 76 | P28562 | |
| HLTGELYVGQLIAEA | 536 | Q9NY28 | |
| ELTNHAVLLVGYGTD | 401 | P53634 | |
| SGEHLTAAVESILYL | 96 | Q96P44 | |
| VVAGAIAAVFHTLIA | 91 | Q9HCJ1 | |
| IAAVFHTLIAYSDLG | 96 | Q9HCJ1 | |
| HGTIYASAELAVQAL | 401 | Q02246 | |
| RSYDEAILHLVVAGL | 131 | Q7KYR7 | |
| HDVLAAALYGAATGI | 101 | Q9BSK0 | |
| VFTGALIYAIHAEEI | 111 | P54852 | |
| SAGLVRHLEEYAATL | 2291 | Q9NYQ7 | |
| DHAAAAIAKAGIPVY | 86 | P23526 | |
| EGAIYHLASILFVVG | 26 | Q9HBV1 | |
| RVAAVSTHVALGAYA | 316 | Q14623 | |
| AYDHSRVLLSAIEGI | 1391 | P23468 | |
| GLDVLAIGVSYAHIL | 226 | Q8NGH7 | |
| GLDVLAIGVSYAHIL | 226 | Q8NGH6 | |
| LVETAAHLGYSVVAI | 21 | P78346 | |
| TVAVRDLLAHGLYAS | 431 | Q96C34 | |
| LGDAVVEFLTSVHLY | 971 | Q9NRR4 | |
| IGYVTGVLAVLVHAA | 156 | Q5M8T2 | |
| AVFAVSAVVHEYALA | 451 | P35610 | |
| HEALLYYVLAAETGI | 891 | Q68CR1 | |
| SSLVVSLAHGAVIYA | 1541 | O95602 | |
| QEGGAAHVVAAYSLV | 631 | O95754 | |
| AEVASAIGYLHSLNI | 141 | Q9HBY8 | |
| YTNLHAVLLGDATEA | 141 | Q16647 | |
| FHLVYVDAIAIAIVG | 336 | P58743 | |
| LLQGSVVADHDYIGL | 436 | Q9NXP7 | |
| GRLAYHLAVVLGSAA | 306 | Q9HAB3 | |
| ALDSRVGLHAYDISV | 26 | Q2M3M2 | |
| NGLYVLAGVAESIHL | 91 | Q9BV38 | |
| IVLVAYSALGSHREE | 211 | Q04828 | |
| IVLVAYSALGSHREE | 211 | P52895 | |
| GAYFRVLAEHGVAAL | 376 | Q9H6R3 | |
| DVVDGTYVAHVDLAL | 226 | Q96JI7 | |
| RALLQAYIDGHSVVI | 56 | Q16881 | |
| VLLTGLHAVADIYCE | 66 | O60688 | |
| LHSVEVEVSYFAAGI | 591 | Q9C0D3 | |
| VEVSYFAAGIIAHLI | 596 | Q9C0D3 | |
| GSDTLLGAIIIHEVY | 1646 | O75970 | |
| NAASYGHVDIAALLI | 876 | O95271 | |
| QYHSLDVIGFLLAVV | 486 | P35504 | |
| QLAAAREDYVLVAGH | 191 | P13686 | |
| TALAVSHNGVLYIAE | 1471 | Q6N022 | |
| LRTVYAGEHAEAIAS | 1901 | Q9H254 | |
| VLLTGLHAVADIYCE | 66 | Q96QA6 | |
| FTYAIIAAGVAHAIT | 106 | O00755 | |
| LVAAIILAGIYINGH | 436 | Q8IUK5 | |
| AFAYAIAAAGVVHAV | 131 | Q9GZT5 | |
| TLNHSAGVVEALYEA | 2011 | O15050 | |
| LIAIVYSHEARAALG | 206 | A0A1B0GWB2 | |
| HAVSYINVGVLHALD | 321 | A0A286YF58 | |
| GALGETALHIAALYD | 76 | Q9NQA5 | |
| YVSHELVNAALLAGS | 596 | A8MPX8 | |
| QYHSLDVIGFLLAVV | 486 | P22310 | |
| HEAESYVALVLVFAL | 181 | Q8IZS6 | |
| TALHVAAAKGYTEVL | 201 | O14974 |